Hollsteen
← NVIDIA

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $339M · 10-Q 0001045810-15-000097 filed May 20, 2015Research and development · Q2 FY2016: $320M · 10-Q 0001045810-15-000143 filed Aug 19, 2015Research and development · Q3 FY2016: $329M · 10-Q 0001045810-15-000173 filed Nov 18, 2015Research and development · Q4 FY2016: $344M · derived · 10-K 0001045810-17-000027 filed Mar 1, 2017Research and development · Q1 FY2017: $346M · 10-Q 0001045810-16-000275 filed May 25, 2016Research and development · Q2 FY2017: $350M · 10-Q 0001045810-16-000300 filed Aug 23, 2016Research and development · Q3 FY2017: $373M · 10-Q 0001045810-16-000353 filed Nov 22, 2016Research and development · Q4 FY2017: $394M · derived · 10-K 0001045810-18-000010 filed Feb 28, 2018Research and development · Q1 FY2018: $411M · 10-Q 0001045810-17-000075 filed May 23, 2017Research and development · Q2 FY2018: $416M · 10-Q 0001045810-17-000123 filed Aug 23, 2017Research and development · Q3 FY2018: $462M · 10-Q 0001045810-17-000172 filed Nov 21, 2017Research and development · Q4 FY2018: $507M · derived · 10-K 0001045810-19-000023 filed Feb 21, 2019Research and development · Q1 FY2019: $542M · 10-Q 0001045810-18-000080 filed May 22, 2018Research and development · Q2 FY2019: $581M · 10-Q 0001045810-18-000114 filed Aug 16, 2018Research and development · Q3 FY2019: $605M · 10-Q 0001045810-18-000150 filed Nov 15, 2018Research and development · Q4 FY2019: $647M · derived · 10-K 0001045810-20-000010 filed Feb 20, 2020Research and development · Q1 FY2020: $674M · 10-Q 0001045810-19-000079 filed May 16, 2019Research and development · Q2 FY2020: $704M · 10-Q 0001045810-19-000144 filed Aug 15, 2019Research and development · Q3 FY2020: $712M · 10-Q 0001045810-19-000170 filed Nov 14, 2019Research and development · Q4 FY2020: $738M · derived · 10-K 0001045810-21-000010 filed Feb 26, 2021Research and development · Q1 FY2021: $735M · 10-Q 0001045810-20-000065 filed May 21, 2020Research and development · Q2 FY2021: $997M · 10-Q 0001045810-20-000147 filed Aug 19, 2020Research and development · Q3 FY2021: $1.0B · 10-Q 0001045810-20-000189 filed Nov 18, 2020Research and development · Q4 FY2021: $1.1B · derived · 10-K 0001045810-22-000036 filed Mar 18, 2022Research and development · Q1 FY2022: $1.2B · 10-Q 0001045810-21-000064 filed May 26, 2021Research and development · Q2 FY2022: $1.2B · 10-Q 0001045810-21-000131 filed Aug 20, 2021Research and development · Q3 FY2022: $1.4B · 10-Q 0001045810-21-000163 filed Nov 22, 2021Research and development · Q4 FY2022: $1.5B · derived · 10-K 0001045810-23-000017 filed Feb 24, 2023Research and development · Q1 FY2023: $1.6B · 10-Q 0001045810-22-000079 filed May 27, 2022Research and development · Q2 FY2023: $1.8B · 10-Q 0001045810-22-000147 filed Aug 31, 2022Research and development · Q3 FY2023: $1.9B · 10-Q 0001045810-22-000166 filed Nov 18, 2022Research and development · Q4 FY2023: $2.0B · derived · 10-K 0001045810-24-000029 filed Feb 21, 2024Research and development · Q1 FY2024: $1.9B · 10-Q 0001045810-23-000093 filed May 26, 2023Research and development · Q2 FY2024: $2.0B · 10-Q 0001045810-23-000175 filed Aug 28, 2023Research and development · Q3 FY2024: $2.3B · 10-Q 0001045810-23-000227 filed Nov 21, 2023Research and development · Q4 FY2024: $2.5B · derived · 10-K 0001045810-25-000023 filed Feb 26, 2025Research and development · Q1 FY2025: $2.7B · 10-Q 0001045810-24-000124 filed May 29, 2024Research and development · Q2 FY2025: $3.1B · 10-Q 0001045810-24-000264 filed Aug 28, 2024Research and development · Q3 FY2025: $3.4B · 10-Q 0001045810-24-000316 filed Nov 20, 2024Research and development · Q4 FY2025: $3.7B · derived · 10-K 0001045810-26-000021 filed Feb 25, 2026Research and development · Q1 FY2026: $4.0B · 10-Q 0001045810-25-000116 filed May 28, 2025Research and development · Q2 FY2026: $4.3B · 10-Q 0001045810-25-000209 filed Aug 27, 2025Research and development · Q3 FY2026: $4.7B · 10-Q 0001045810-25-000230 filed Nov 19, 2025Research and development · Q4 FY2026: $5.5B · derived · 10-K 0001045810-26-000021 filed Feb 25, 2026Research and development · Q1 FY2027: $6.3B · 10-Q 0001045810-26-000052 filed May 20, 2026Research and development · Q2 FY2027: $7.1B · 10-Q 0001045810-26-000075 filed Aug 26, 20264,7057,054339Q1 FY2016Q2 FY2027
$MResearch and development · Q3 FY2025: $3.4B · 10-Q 0001045810-24-000316 filed Nov 20, 2024Research and development · Q4 FY2025: $3.7B · derived · 10-K 0001045810-26-000021 filed Feb 25, 2026Research and development · Q1 FY2026: $4.0B · 10-Q 0001045810-25-000116 filed May 28, 2025Research and development · Q2 FY2026: $4.3B · 10-Q 0001045810-25-000209 filed Aug 27, 2025Research and development · Q3 FY2026: $4.7B · 10-Q 0001045810-25-000230 filed Nov 19, 2025Research and development · Q4 FY2026: $5.5B · derived · 10-K 0001045810-26-000021 filed Feb 25, 2026Research and development · Q1 FY2027: $6.3B · 10-Q 0001045810-26-000052 filed May 20, 2026Research and development · Q2 FY2027: $7.1B · 10-Q 0001045810-26-000075 filed Aug 26, 20264,7057,0543,390Q3 FY2025Q2 FY2027Q3 FY2026
Q3 FY2026
4,705$M
All values (46)
PeriodValue ($M)Status
Q2 FY20277,054reported
Q1 FY20276,321reported
Q4 FY20265,512derived
Q3 FY20264,705reported
Q2 FY20264,291reported
Q1 FY20263,989reported
Q4 FY20253,714derived
Q3 FY20253,390reported
Q2 FY20253,090reported
Q1 FY20252,720reported
Q4 FY20242,465derived
Q3 FY20242,294reported
Q2 FY20242,040reported
Q1 FY20241,875reported
Q4 FY20231,952derived
Q3 FY20231,945reported
Q2 FY20231,824reported
Q1 FY20231,618reported
Q4 FY20221,466derived
Q3 FY20221,403reported
Q2 FY20221,245reported
Q1 FY20221,153reported
Q4 FY20211,146derived
Q3 FY20211,047reported
Q2 FY2021997reported
Q1 FY2021735reported
Q4 FY2020738derived
Q3 FY2020712reported
Q2 FY2020704reported
Q1 FY2020674reported
Q4 FY2019647derived
Q3 FY2019605reported
Q2 FY2019581reported
Q1 FY2019542reported
Q4 FY2018507derived
Q3 FY2018462reported
Q2 FY2018416reported
Q1 FY2018411reported
Q4 FY2017394derived
Q3 FY2017373reported
Q2 FY2017350reported
Q1 FY2017346reported
Q4 FY2016344derived
Q3 FY2016329reported
Q2 FY2016320reported
Q1 FY2016339reported

CSV with all sources · Technical ID: rnd

More metrics for NVIDIA

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$4.7B
Period
Q3 FY2026, ended Oct 26, 2025 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Nov 19, 2025 · 0001045810-25-000230
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$4.7BNov 19, 202510-Q 0001045810-25-000230reported · confidence 1. · current